Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA

Neoplasma

Volumn 60, Issue 4, 2013, Pages 384-394

  Dai, N ^a   Zhong, Z Y ^a   Cun, Y P ^a   Qing, Y ^a   Chen, Ch ^a   Jiang, P ^a   Li, M X ^a   Wang, D ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

APE1; Bioinformatics; Microarray; microRNA; Osteosarcoma

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; MICRORNA; MICRORNA 197; MICRORNA 29B; MICRORNA 324 5P; MICRORNA 451; MICRORNA 483 5P; MICRORNA 484; MICRORNA 513A 5P; MICRORNA 765; MICRORNA LET 7B; MICRORNA LET 7I; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; APEX1 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; OSTEOSARCOMA; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; BIOLOGY; BONE TUMOR; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

BINDING SITES; BONE NEOPLASMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DOWN-REGULATION; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; OSTEOSARCOMA; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFECTION;

MLCS; MLOWN;

EID: 84880432053     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_050     Document Type: Article

References (42)

1. WANG LL. Biology of osteogenic sarcoma. Cancer J 2005; 11: 294-305. http://dx.doi.org/10.1097/00130404-200507000-00005
2. OTTAVIANI G AND JAFFE N. The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3-13. http://dx.doi.org/10.1007/978-1-4419-0284-9_1
3. DELANEY TF, PARK L, GOLDBERG SI, HUG EB, LIEBSCH NJ, et al. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 2005; 61: 492-498. http://dx.doi.org/10.1016/j.ijrobp.2004.05.051
4. FERRARI S, BERTONI F, MERCURI M, PICCI P, GIACOMINI S, et al. Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol 2001; 12: 1145-1150. http://dx.doi.org/10.1023/A:1011636912674
5. TELL G, FANTINI D AND QUADRIFOGLIO F. Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment. Cell Mol Life Sci 2010; 67: 3589-3608. http://dx.doi.org/10.1007/s00018-010-0486-4
6. EVANS AR, LIMP-FOSTER M AND KELLEY MR. Going APE over ref-1. Mutat Res 2000; 461: 83-108. http://dx.doi.org/10.1016/S0921-8777(00)00046-X
7. FISHEL ML AND KELLEY MR. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 2007; 28: 375-395. http://dx.doi.org/10.1016/j.mam.2007.04.005
8. WANG D, LUO M AND KELLEY MR. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 2004; 3: 679-686.
9. WANG D, ZHONG ZY, LI MX AND LI ZP. Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo. Cancer Sci 2007; 98: 1993-2001. http://dx.doi.org/10.1111/j.1349-7006.2007.00616.x
10. XIANG DB, CHEN ZT, WANG D, LI MX, XIE JY, et al. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo. Cancer Gene Ther 2008; 15: 625-635. http://dx.doi.org/10.1038/cgt.2008.30
11. BUSSO CS, LAKE MW AND IZUMI T. Posttranslational modification of mammalian AP endonuclease (APE1). Cell Mol Life Sci 2010; 67: 3609-3620. http://dx.doi.org/10.1007/s00018-010-0487-3
12. ESQUELA-KERSCHER A AND SLACK FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269. http://dx.doi.org/10.1038/nrc1840
13. BARTEL DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5
14. CHO WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6: 60. http://dx.doi.org/10.1186/1476-4598-6-60
15. ZHANG Y, GAO JS, TANG X, TUCKER LD, QUESENBERRY P, et al. MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Lett 2009; 583: 3725-3730. http://dx.doi.org/10.1016/j.febslet.2009.10.002
16. LE MT, TEH C, SHYH-CHANG N, XIE H, ZHOU B, et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 2009; 23: 862-876. http://dx.doi.org/10.1101/gad.1767609
17. KUMAR M, LU Z, TAKWI AA, CHEN W, CALLANDER NS, et al. Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 2011; 30: 843-853. http://dx.doi.org/10.1038/onc.2010.457
18. HE L, HE X, LOWE SW and HANNON GJ. microRNAs join the p53 network--another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007; 7: 819-822. http://dx.doi.org/10.1038/nrc2232
19. KIM WC, KING D AND LEE CH. RNA-cleaving properties of human apurinic/apyrimidinic endonuclease 1 (APE1). Int J Biochem Mol Biol 2010; 1: 12-25.
20. XI Y, SHALGI R, FODSTAD O, PILPEL Y and JU J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 2006; 12: 2014-2024. http://dx.doi.org/10.1158/1078-0432.CCR-05-1853
21. ZHOU X, REN Y, HAN L, MEI M, XU P, et al. Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells. Int J Oncol 2010; 36: 665-672.
22. BADER AG, BROWN D, STOUDEMIRE J and LAMMERS P. Developing therapeutic microRNAs for cancer. Gene Ther 2011; 18: 1121-1126. http://dx.doi.org/10.1038/gt.2011.79
23. GOUGELET A, PISSALOUX D, BESSE A, PEREZ J, DUC A, et al. Micro-RNA profiles in osteosarcoma as a predictive
24. OSAKI M, TAKESHITA F, SUGIMOTO Y, KOSAKA N, YAMAMOTO Y, et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther 2011; 19: 1123-1130. http://dx.doi.org/10.1038/mt.2011.53
25. LULLA RR, COSTA FF, BISCHOF JM, CHOU PM, DE F BONALDO M, ET al. Identification of Differentially Expressed MicroRNAs in Osteosarcoma. Sarcoma 2011. 732690.
26. CREIGHTON CJ, FOUNTAIN MD, YU Z, NAGARAJA AK, ZHU H, et al. Anderson, Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res 2010; 70: 1906-1915. http://dx.doi.org/10.1158/0008-5472.CAN-09-3875
27. MAIRE G, MARTIN JW, YOSHIMOTO M, CHILTONMACNEILL S, ZIELENSKA M et al. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. Cancer Genet 2011; 204: 138-146. http://dx.doi.org/10.1016/j.cancergen.2010.12.012
28. LEWIS BP, BURGE CB and BARTEL DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20. http://dx.doi.org/10.1016/j.cell.2004.12.035
29. VAN JAARSVELD MT, HELLEMAN J, BERNS EM and WIEMER EA. MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol 2010; 42: 1282-1290. http://dx.doi.org/10.1016/j.biocel.2010.01.014
30. KOVALCHUK O, FILKOWSKI J, MESERVY J, ILNYTSKYY Y, TRYNDYAK VP, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 2008; 7: 2152-2159. http://dx.doi.org/10.1158/1535-7163.MCT-08-0021
31. CHATTOPADHYAY R, DAS S, MAITI AK, BOLDOGH I, XIE J, et al. Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. Mol Cell Biol 2008; 28: 7066-7080. http://dx.doi.org/10.1128/MCB.00244-08
32. BHAKAT KK, MANTHA AK and MITRA S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 2009; 11: 621-638. http://dx.doi.org/10.1089/ars.2008.2198
33. MOTT JL, KURITA S, CAZANAVE SC, BRONK S, WERNEBURG NW et al. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NFkappaB. J Cell Biochem 2010; 110: 1155-1164. http://dx.doi.org/10.1002/jcb.22630
34. SARA M WEIS and DAVID A CHERESH. Tumor angiogenesis: molecular pathways and therapeutic targets. Nature Medicine 2011; 17: 1359-1370. http://dx.doi.org/10.1038/nm.2537
35. HAFSI H and HAINAUT P. Redox Control and Interplay Between p53 Isoforms: Roles in the Regulation of Basal p53 Levels, Cell Fate, and Senescence. Antioxid Redox Signal 2011; 15: 1655-1667. http://dx.doi.org/10.1089/ars.2010.3771
36. BUSSO CS, IWAKUMA T AND IZUMI T. Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway. Oncogene 2009; 28: 1616-1625. http://dx.doi.org/10.1038/onc.2009.5
37. ZHANG Y, WANG J, XIANG D, WANG D and XIN X. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Int J Oncol 2009; 35: 1069-1079.
38. KELLEY MR, CHENG L, FOSTER R, TRITT R, JIANG J, et al. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 2001; 7: 824-830.
39. ROBERTSON KA, BULLOCK HA, XU Y, TRITT R, ZIMMERMAN E, et al: Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 2001; 61: 2220-2225.
40. WANG D, XIANG DB, YANG XQ, CHEN LS, LI MX, et al. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Lung Cancer 2009; 66: 298-304. http://dx.doi.org/10.1016/j.lungcan.2009.02.019
41. YUK JM, YANG CS, SHIN DM, KIM KK, LEE SK, et al. A dual regulatory role of apurinic/apyrimidinic endonuclease 1/redox factor-1 in HMGB1-induced inflammatory responses. Antioxid Redox Signal 2009; 11: 575-588. http://dx.doi.org/10.1089/ars.2008.2196
42. WANG D, ZHONG ZY, LI ZP, YANG ZZ AND KELLEY MR. The altered gene profile of human osteosarcoma cell after knock-down of double functional gene apurinic/apyrimidinic endonuclease. ACTA Academiae Medicinae Militaris Tertiae 2007; 29: 1-4.